{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:55:43Z","timestamp":1790204143630,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011926","name":"European Association for Haemophilia and Allied Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011926","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Vessels, Thrombosis & Hemostasis"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bvth.2025.100095","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T22:06:29Z","timestamp":1752876389000},"page":"100095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["F9 missense variant hot spots associated with qualitative protein defects causing hemophilia B"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8069-6631","authenticated-orcid":false,"given":"Tirsa T.","family":"van Duijl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1957-4122","authenticated-orcid":false,"given":"Samantha","family":"Gouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1431-172X","authenticated-orcid":false,"given":"Ina","family":"Kronevska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9859-8812","authenticated-orcid":false,"given":"Alette","family":"Kooiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1146-0136","authenticated-orcid":false,"given":"Wil F.","family":"Kopatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9975-7827","authenticated-orcid":false,"given":"Nadia","family":"Freato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Beijlevelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6544-2331","authenticated-orcid":false,"given":"Henrike M.","family":"Hamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0904-4360","authenticated-orcid":false,"given":"Karin","family":"Fijnvandraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4198-6780","authenticated-orcid":false,"given":"Joost C. M.","family":"Meijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6970-5496","authenticated-orcid":false,"given":"Maartje","family":"van den Biggelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bvth.2025.100095_bib1","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jtha.2023.12.031","article-title":"Pleiotropic effects of different exonic nucleotide changes at the same position contribute to hemophilia B phenotypic variation","volume":"22","author":"Zhang","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"suppl 6","key":"10.1016\/j.bvth.2025.100095_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH guidelines for the management of hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.bvth.2025.100095_bib3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jtha.2023.09.029","article-title":"Patients with moderate hemophilia A and B with a severe bleeding phenotype have an increased burden of disease","volume":"22","author":"Verhagen","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"suppl 3","key":"10.1016\/j.bvth.2025.100095_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/hae.14990","article-title":"Outcomes and outcome measures","volume":"30","author":"Castaman","year":"2024","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.bvth.2025.100095_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.70111","article-title":"Mild or moderate hemophilia is not always a mild or moderate bleeding disorder: back to the clinical phenotype","volume":"9","author":"Rodeghiero","year":"2025","journal-title":"Hemasphere"},{"issue":"3","key":"10.1016\/j.bvth.2025.100095_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/ejh.14135","article-title":"The current challenges faced by people with hemophilia B","volume":"112","author":"Miesbach","year":"2024","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.bvth.2025.100095_bib7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/hae.14300","article-title":"The function of extravascular coagulation factor IX in haemostasis","volume":"27","author":"Mann","year":"2021","journal-title":"Haemophilia"},{"issue":"12","key":"10.1016\/j.bvth.2025.100095_bib8","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1073\/pnas.74.12.5260","article-title":"Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation","volume":"74","author":"Osterud","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"41","key":"10.1016\/j.bvth.2025.100095_bib9","doi-asserted-by":"crossref","first-page":"25332","DOI":"10.1074\/jbc.271.41.25332","article-title":"Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding","volume":"271","author":"Lenting","year":"1996","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.bvth.2025.100095_bib10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1182\/blood.V108.11.334.334","article-title":"Independence of factor XIa subunits in factor IX activation","volume":"108","author":"Smith","year":"2006","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.bvth.2025.100095_bib11","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1182\/blood.2020005593","article-title":"Factor VIII\u2013driven changes in activated factor IX explored by hydrogen-deuterium exchange mass spectrometry","volume":"136","author":"Freato","year":"2020","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bvth.2025.100095_bib12","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1016\/j.jtha.2024.07.008","article-title":"An integrated multitool analysis contributes elements to interpreting unclassified factor IX missense variants associated with hemophilia B","volume":"22","author":"Sacco","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.bvth.2025.100095_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/jth.15552","article-title":"F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes","volume":"20","author":"Branchini","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"45","key":"10.1016\/j.bvth.2025.100095_bib14","doi-asserted-by":"crossref","first-page":"38200","DOI":"10.1074\/jbc.M112.376343","article-title":"A sequential mechanism for exosite-mediated factor IX activation by factor Xia","volume":"287","author":"Geng","year":"2012","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.bvth.2025.100095_bib15","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1182\/blood.2023021944","article-title":"Enhanced procoagulant activity of select hemophilia B causing factor IX variants with emicizumab","volume":"144","author":"Lee","year":"2024","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bvth.2025.100095_bib16","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.jtha.2023.02.005","article-title":"An updated interactive database for 1692 genetic variants in coagulation factor IX provides detailed insights into hemophilia B","volume":"21","author":"Xu","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1016\/j.bvth.2025.100095_bib17","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/jth.12276","article-title":"An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B","volume":"11","author":"Rallapalli","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.bvth.2025.100095_bib18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/humu.20214","article-title":"Factor XI deficiency database: an interactive web database of mutations, phenotypes, structural analysis tools","volume":"26","author":"Saunders","year":"2005","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.bvth.2025.100095_bib19","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/hae.13947","article-title":"The European Association for Haemophilia and Allied Disorders (EAHAD) coagulation factor variant databases: important resources for haemostasis clinicians and researchers","volume":"26","author":"McVey","year":"2020","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.bvth.2025.100095_bib20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/s-0038-1653759","article-title":"The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability","volume":"73","author":"Verbruggen","year":"1995","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.bvth.2025.100095_bib21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jtha.2023.10.009","article-title":"Reversal of factor XI targeting anticoagulants: an in vitro evaluation","volume":"22","author":"Bakhtiari","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"04","key":"10.1016\/j.bvth.2025.100095_bib22","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1055\/s-0037-1615639","article-title":"Modeling human zymogen factor IX","volume":"85","author":"Perera","year":"2001","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.bvth.2025.100095_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0092-8674(95)90059-4","article-title":"The structure of a Ca2+-binding epidermal growth factor-like domain: its role in protein-protein interactions","volume":"82","author":"Rao","year":"1995","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bvth.2025.100095_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"issue":"10","key":"10.1016\/j.bvth.2025.100095_bib25","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1080\/13696998.2019.1620246","article-title":"Systematic review and analysis of efficacy of recombinant factor IX products for prophylactic treatment of hemophilia B in comparison with rIX-FP","volume":"22","author":"Davis","year":"2019","journal-title":"J Med Econ"},{"issue":"suppl 3","key":"10.1016\/j.bvth.2025.100095_bib26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2516.2006.01261.x","article-title":"Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophilia","volume":"12","author":"Astermark","year":"2006","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.bvth.2025.100095_bib27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.gt.3302881","article-title":"Transgene expression levels and kinetics determine risk of humoral immune response modeled in factor IX knockout and missense mutant mice","volume":"14","author":"Zhang","year":"2007","journal-title":"Gene Ther"},{"issue":"5","key":"10.1016\/j.bvth.2025.100095_bib28","article-title":"Breaking sex biases: access for all in haemophilia care","volume":"12","author":"Haematology","year":"2025","journal-title":"Lancet Haematol"},{"issue":"4","key":"10.1016\/j.bvth.2025.100095_bib29","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/hae.13219","article-title":"Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B","volume":"23","author":"Kihlberg","year":"2017","journal-title":"Haemophilia"},{"issue":"12","key":"10.1016\/j.bvth.2025.100095_bib30","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1111\/jth.14315","article-title":"The definition, diagnosis and management of mild hemophilia A: communication from the SSC of the ISTH","volume":"16","author":"Makris","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.bvth.2025.100095_bib31","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/jth.15237","article-title":"The carboxyl-terminal region of coagulation serine proteases: a matter of cut and change","volume":"19","author":"Branchini","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.bvth.2025.100095_bib32","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1055\/s-0037-1614078","article-title":"Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex","volume":"84","author":"Wu","year":"2000","journal-title":"Thromb Haemost"},{"issue":"9","key":"10.1016\/j.bvth.2025.100095_bib33","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nsb971","article-title":"Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins","volume":"10","author":"Huang","year":"2003","journal-title":"Nat Struct Biol"},{"issue":"7","key":"10.1016\/j.bvth.2025.100095_bib34","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/j.1460-2075.1988.tb03045.x","article-title":"The role of beta-hydroxyaspartate and adjacent carboxylate residues in the first EGF domain of human factor IX","volume":"7","author":"Rees","year":"1988","journal-title":"EMBO J"},{"issue":"2","key":"10.1016\/j.bvth.2025.100095_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0022-2836(83)80024-2","article-title":"Refined crystal structure of carboxypeptidase a at 1\u00b754 \u00c5 resolution","volume":"168","author":"Rees","year":"1983","journal-title":"J Mol Biol"},{"issue":"12","key":"10.1016\/j.bvth.2025.100095_bib36","doi-asserted-by":"crossref","first-page":"6751","DOI":"10.1074\/jbc.270.12.6751","article-title":"The calcium binding properties and molecular organization of epidermal growth factor-like domains in human fibrillin-1 (\u2217)","volume":"270","author":"Handford","year":"1995","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.bvth.2025.100095_bib37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1365-2141.1991.tb07955.x","article-title":"Identification of haemophilia B patients with mutations in the two calcium binding domains of factor IX: importance of a \u03b2-OH Asp 64\u2192Asn change","volume":"77","author":"Winship","year":"1991","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.bvth.2025.100095_bib38","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1182\/blood.V75.5.1097.1097","article-title":"Factor IX new London: substitution of proline for glutamine at position 50 causes severe hemophilia B","volume":"75","author":"Lozier","year":"1990","journal-title":"Blood"},{"issue":"5022","key":"10.1016\/j.bvth.2025.100095_bib39","first-page":"909","article-title":"Factor XI activation in a revised model of blood coagulation","volume":"253","author":"Gailani","year":"1991","journal-title":"Science (1979)"},{"issue":"13","key":"10.1016\/j.bvth.2025.100095_bib40","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/blood-2009-09-199182","article-title":"Structure and function of factor XI","volume":"115","author":"Emsley","year":"2010","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bvth.2025.100095_bib41","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1182\/blood.V86.8.3035.3035","article-title":"Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis","volume":"86","author":"von dem Borne","year":"1995","journal-title":"Blood"}],"container-title":["Blood Vessels, Thrombosis & Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S295032722500052X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S295032722500052X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:28:18Z","timestamp":1764170898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S295032722500052X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S295032722500052X"],"URL":"https:\/\/doi.org\/10.1016\/j.bvth.2025.100095","relation":{},"ISSN":["2950-3272"],"issn-type":[{"value":"2950-3272","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"F9 missense variant hot spots associated with qualitative protein defects causing hemophilia B","name":"articletitle","label":"Article Title"},{"value":"Blood Vessels, Thrombosis & Hemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bvth.2025.100095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100095"}}